Neogen Corporation updated earnings guidance for its full-year 2025. For the year, the company now expected its revenue to be in the range of $905 million to $925 million. Primarily due to the strengthening of the U.S. dollar and, to a lesser degree, a delay in the ramp-up of sample collection production and the voluntary attrition of genomics revenue related to restructuring activities.